Physician

Adam Bernard Woldow, M.D.

According to 2025 Medicare claims, Adam Woldow, M.D. (NPI: 1750583316) practices dermatology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is CERTIFIED DERMATOLOGY PC (NPI: 1932592144; TIN: 473297283) and primary practice location at 18954-1082.

Woldow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 996 traditional Medicare patients, billed 6,082 HCPCS/CPT codes, and received $510,417 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,791 prescription claims across 1,044 beneficiaries totaling $987,301 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 54 records totaling $580. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $97,651 to $510,417. Similarly, Part D prescription costs have risen steadily, from $58,649 to $987,301. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$255K$510K2015 Medicare payment: $97,651 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $154,421 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $246,744 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $237,548 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $327,252 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $291,074 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $311,262 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $298,136 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $340,658 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $510,417 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152952,042$97,651
20164453,526$154,421
20175984,952$246,744
20186564,118$237,548
20197184,881$327,252
20207365,000$291,074
20217914,716$311,262
20228564,250$298,136
20239265,094$340,658
20249966,082$510,417

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$494K$987K2015 Drug cost: $58,649 (USD; Tot_Drug_Cst)2016 Drug cost: $147,060 (USD; Tot_Drug_Cst)2017 Drug cost: $259,045 (USD; Tot_Drug_Cst)2018 Drug cost: $186,788 (USD; Tot_Drug_Cst)2019 Drug cost: $206,150 (USD; Tot_Drug_Cst)2020 Drug cost: $335,115 (USD; Tot_Drug_Cst)2021 Drug cost: $620,268 (USD; Tot_Drug_Cst)2022 Drug cost: $825,652 (USD; Tot_Drug_Cst)2023 Drug cost: $827,813 (USD; Tot_Drug_Cst)2024 Drug cost: $987,301 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015200429$58,649
2016261612$147,060
2017299782$259,045
2018321780$186,788
20193791,019$206,150
20205381,458$335,115
20216731,828$620,268
20227652,107$825,652
20239032,440$827,813
20241,0442,791$987,301

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths250301$83
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7211,149$71
11102Biopsy of related skin growth, first growth317372$68
17000Destruction of precancer skin growth, 1 growth282371$40
17003Destruction of precancer skin growth, 2-14 growths167734$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11868$234,635
Dupixent PenDupilumab401,120$151,407
Cosentyx Sensoready (2 Pens)Secukinumab11308$100,110
Cosentyx (2 Syringes)Secukinumab13364$94,295
Taltz AutoinjectorIxekizumab11308$78,883

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.54$580ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Bernard Woldow, M.D.?

Tedicare shows public-source Medicare data for Adam Bernard Woldow, M.D. (NPI 1750583316), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Bernard Woldow, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Bernard Woldow, M.D.?

Adam Bernard Woldow, M.D. is linked to CERTIFIED DERMATOLOGY PC (billing NPI 1932592144) in the available physician profile data.

Does Adam Bernard Woldow, M.D. have Open Payments data?

Adam Bernard Woldow, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.